Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (d,l-lactide) oligomers

Journal of Controlled Release

Volumn 58, Issue 3, 1999, Pages 311-322

  Géze, Annabelle ^a   Venier Julienne, Marie Claire ^a   Saulnier, Patrick ^a   Varlet, Pascale ^b   Daumas Duport, Catherine ^b   Devauchelle, Patrick ^c   Benoit, Jean Pierre ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b Service d'Anatomie Pathologique   (France)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

Author keywords

Biodegradable microspheres; D,L PLA oligomers; IdUrd; Phase separation; Tumor culture

Indexed keywords

IDOXURIDINE; MICROSPHERE; POLYGLACTIN; POLYLACTIDE; RADIOSENSITIZING AGENT;

ARTICLE; BRAIN; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG RELEASE; DRUG SYNTHESIS; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; IN VITRO STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; TISSUE CULTURE; TUMOR CELL;

BIODEGRADATION, ENVIRONMENTAL; BRAIN; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; IDOXURIDINE; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0344096734     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00165-5     Document Type: Article

References (20)

1. Daumas-Duport C., Tucker M.L., Colles H., Cervera P., Beuvon F., Varlet P. Oligodendroglioma. Part II: A new grading system based on morphological and imaging criteria. J. Neuro-Oncol. 34:1997;61-78.
2. Djordjevic B., Szybalski W. Genetics of human cell lines. III. Incorporation of 5-bromo and 5-iododeoxyuridine into the deoxyribonucleic acid on human cells and its effect on radiation sensitivity. J. Exp. Med. 112:1960;509-531.
3. Menei P., Benoit J.P., Boisdron-Celle M., Fournier D., Mercier P., Guy G. Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres. Neurosurgery. 34(6):1994;1058-1064.
4. Menei P., Daniel V., Montero-Menei C., Brouillard M., Pouplard-Barthelaix A., Benoit J.P. Biodegradation and brain tissue reaction to poly (D,L-lactide-co-glycolide) microspheres. Biomaterials. 14(6):1993;470-478.
5. Ruiz J.M., Tissier B., Benoit J.P. Microencapsulation of peptide: a study of the phase separation of poly (D,L-lactic acid-co-glycolic acid) copolymers 50/50 by silicone oil. Int. J. Pharm. 49:1989;69-77.
6. Ruiz J.M., Busnel J.P., Benoit J.P. Influence of average molecular weights of poly (DL-lactic acid-co-glycolic acid) copolymers 50/50 on phase separation and in vitro drug release from microspheres. Pharm. Res. 7(9):1990;928-934.
7. Thomasin C., Gander B., Merkle H.P. Physicochemical characterization of the coacervation process of poly(l-lactic acid) and poly(d,l-lactic acid) by silicone oil. Proceed. Int. Symp. Cont. Rel. Bioact. Mater. 18:1991;646-647.
8. Stassen S., Nihant N., Martin V., Grandfils C., Jérôme R., Teyssié Ph. Microencapsulation by coacervation of poly(lactide-co-glycolide): 1. Physico-chemical characteristics of the phase separation process. Polymer. 35(4):1994;777-785.
9. Hsu S.M., Raine L., Fanger H. The use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
10. Ruiz J.M., Benoit J.P. In vivo peptide release from poly (D,L-lactic acid-co-glycolic acid) copolymer 50/50 microspheres. J. Control. Release. 16:1991;177-186.
11. Menei P., Boisdron-Celle M., Croué A., Guy G., Benoit J.P. Effect of stereotactic implantation of biodegradable 5-Fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery. 39(1):1996;1-8.
12. Vidil C., Braud C., Garreau H., Vert M. Monitoring of the poly(D,L-lactic acid) degradation by-products by capillary zone electrophoresis. J. Chrom. A. 711:1995;323-329.
13. Pitt C.G., Jeffcoat A.R., Zweidinger R.A., Schindler A. Sustained drug delivery systems. I. The permeability of poly(ε-caprolactone), poly(D,L-lactic acid), and their copolymers. J. Biomed. Mater. Res. 13:1979;497-507.
14. Juni K., Ogata J., Matsui N., Kubota M., Nakano M. Modification of the release rate of aclarubicin from polylactic acid microspheres by using additives. Chem. Pharm. Bull. 33(4):1985;1734-1738.
15. Juni K., Ogata J., Matsui N., Kubota M., Nakano M. Control of release rate of bleomycin from polylactic acid microspheres by additives. Chem. Pharm. Bull. 33(4):1985;1609-1614.
16. Cha Y., Pitt C.G. The acceleration of degradation-controlled drug delivery from polyester microspheres. J. Control. Release. 8:1989;259-265.
17. Maulding H.V., Tice T.R., Cowsar D.R., Fong J.W., Pearson J.E., Nazareno J.P. Biodegradable microcapsules: acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. J. Control. Release. 3:1986;103-117.
18. Bodmeier R., Oh K.H., Chen H. The effect of the addition of low molecular weight poly(D,L-lactide) on drug release from biodegradable poly(D,L-lactide) drug delivery systems. J. Control. Release. 51:1989;1-8.
19. Grandfils C., Flandroy P., Jérôme R. Control of the biodegradation rate of poly (DL-lactide) microparticles intended as chemoembolization materials. J. Control. Release. 38:1996;109-122.
20. Sah H., Toddywala R., Chien Y.W. The influence of biodegradable microcapsule formulations on the controlled release of a protein. J. Control. Release. 30:1994;201-211.